Trial site
Centre Hospitalier De Tourcoing
Tourcoing Cedex, 59208, FranceNot linked to an institution yet
- 13running trials
- 8closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Phase
- Phase 313 trials
- Phase 25 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting9 trials
- Completed8 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Centre Hospitalier Universitaire Amiens Picardie3 trials
- Assistance Publique Hopitaux De Paris2 trials
- Merck Sharp & Dohme LLC2 trials
- Amgen Inc.1 trial
- ANRS Maladies Infectieuses Emergentes1 trial
- and 12 more
Running trials
Not yet recruiting
Early Corticosteroids in Severe Influenza Pneumonia, a phase III randomized controlled trial
2025-524976-40-00· Phase 3· Centre Hospital Region Metz Thionville· Source
Not yet recruiting
Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus
NCT02664740· Phase 1/2· Centre Hospitalier Universitaire de Nīmes· Source
Not yet recruiting
Immunotherapy with a JAK1/JAK2 inhibitor (baricitinib) and an mTORC1 inhibitor (sirolimus), alone and in combination, for the control of HIV-1 replication after antiretroviral treatment interruption: a phase II multicenter, multi-arm, multi-stage, randomized, double-blind, placebo-controlled, adaptative trial
NCT07081763· Phase 2· ANRS Maladies Infectieuses Emergentes· Source
Recruiting
PALETTE - Trial for personalisation of sepsis treatment in children and adults
2025-521371-31-00· Phase 2· Assistance Publique Hopitaux De Paris· Source
Recruiting
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
NCT07266831· Phase 2/3· Merck Sharp & Dohme LLC· Source
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
2024-516654-22-00· Phase 3· Amgen Inc.· Source
Recruiting
Interventional, multicenter, open-label, randomized, non-comparative trial evaluating the safety, in terms of HBV virological control, of 2 antiviral treatment relief strategies, in patients co-infected with the HIV-1 and HBV viruses
2023-508634-34-00· Phase 2· Inserm· Source
Recruiting
MODULO
NCT06774872· Phase 3· Centre De Recherches Et D'Etudes Sur La Pathologie Tropicale Et Le Sida· Source
Recruiting
Comparison of Landiolol versus standard of care for prevention of mortality in patients hospitalized for a septic shock with hypercontractlity: an open label prospective randomized study
2024-518251-31-00· Phase 3· Centre Hospitalier Universitaire Amiens Picardie· Source
Recruiting
Comparison of azathioprine to methotrexate in combination therapy with adalimumab in Crohn’s Disease: an open-label randomized controlled trial
2024-514633-38-00· Phase 3· Centre Hospitalier Universitaire Amiens Picardie· Source
Active, not recruiting
A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravirine and Islatravir compared to a different group that will start treatment with bictegravir/emtricitabine/tenofovir alafenamide
NCT05705349· Phase 3· Merck Sharp & Dohme LLC· Source
Recruiting
DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)
NCT06034938· Phase 2· University Hospital, Caen· Source
Recruiting
A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab
NCT04183608· Phase 4· Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error